FDA Recalls Alprostadil/Procaine Injectable Solution Due to Sterility Concerns
The FDA is recalling 27 vials of Alprostadil/Procaine Injectable Solution because the manufacturer cannot ensure the product is sterile.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, and the rubric specifies that FDA Class II recalls with hospitalization reports or significant injury/property-damage reports are Severe. While the source does not explicitly list hospitalizations, the lack of sterility assurance in an injectable drug presents a significant risk of serious harm, aligning with the Severe classification for high-risk pharmaceutical defects.
Plain-English summary
The U.S. Food and Drug Administration (FDA) has issued a recall for Alprostadil/Procaine, Injectable Solution, 40 MCG/0.1%/ML, 10 mL and 20 mL vials. The recall is being conducted by JD & SN Inc., dba Moses Lake Professional Pharmacy, located in Moses Lake, Washington. The agency has classified this as a Class II recall.
The reason for the recall is a lack of assurance of sterility. The source text indicates that all sterile human compounded drugs within the expiry date are affected. A total of 27 vials are involved in this recall. The distribution pattern is listed as nationwide.
Consumers and healthcare providers should stop using the affected vials immediately. The specific lot codes associated with this recall include t01212015@26, t01292015@12, t02062015@28, t02092015@14, t02182015@37, t03112015@21, t03302015@3, t05182015@26, t06012015@9, t06042015@31, t06102015@29, t06222015@36, t07062015@4, t07312014@30, t08052014@19, t10082014@18, t10132014@8, t10142014@11, t10232014@23, t11072014@7, t11112014@24, t11182014@13, t12152014@15, and t12162014@7. Individuals with questions should contact the recalling firm at (509) 764-2314.
The recalled product
- Product
- ALPROSTADIL/PROCAINE, Injectable Solution, 40 MCG/0.1%/ML, 10 mL and 20 mL vials, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA 98837, (509)764-2314
- Category
- Drug — Injectable Solution
- Affected units
- 27
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- t01212015@26
- t01292015@12
- t02062015@28
- t02092015@14
- t02182015@37
- t03112015@21
- t03302015@3
- t05182015@26
- t06012015@9
- t06042015@31
- t06102015@29
- t06222015@36
- t07062015@4
- t07312014@30
- t08052014@19
- t10082014@18
- t10132014@8
- t10142014@11
- t10232014@23
- t11072014@7
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 101 recalled by JD & SN Inc., dba Moses Lake Professional Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 101 products in this recall →Related recalls
Same manufacturer · JD & SN Inc., dba Moses Lake Professional Pharmacy
See all →- SevereFDA Recalls Estradiol Pellets Due to Lack of Sterility Assurance
FDA (Drugs) · 2015-11-04
- SevereFDA Recalls Sodium Tetradecyl Sulfate Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereMoses Lake Pharmacy Recalls Six Trimix Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereMoses Lake Pharmacy Recalls Compounded Chorionic Gonadotropin Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereFDA Recalls Compounded Progesterone Pellets Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
Same hazard · lack of sterility
See all →- HighRohto Cooling Eye Drops Max Strength Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- HighRohto Cooling Eye Drops Recalled Due to Lack of Assurance of Sterility
FDA (Drugs) · 2026-07-29
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- SeverePemetrexed for Injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-07-15
- SevereAzacitidine for Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15